Triple
T7392984
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | George Church |
E170546
|
entity |
| Predicate | coFounded |
P104
|
FINISHED |
| Object |
Editas Medicine
Editas Medicine is a biotechnology company focused on developing CRISPR-based gene-editing therapies to treat serious genetic diseases.
|
E661988
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69c68a5e2c9081909e713ce866e0060a |
elicitation | completed |
| NER | batch_69c6f224790c819099ceb7c7ac8d00f6 |
ner | completed |
| NED1 | batch_69c810f82ba08190919924b0994a2eee |
ned_source_triple | completed |
| NED2 | batch_69c812c1e9d08190b0e7f052d87011b9 |
ned_description | completed |
| NEDg | batch_69c811f1fe3c8190a591186b19044b5f |
nedg | completed |
Created at: March 27, 2026, 3:09 p.m.